ISRCTN ISRCTN67723958
DOI https://doi.org/10.1186/ISRCTN67723958
Secondary identifying numbers 1; NTR736
Submission date
12/10/2006
Registration date
12/10/2006
Last edited
16/05/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Ms M Hagelstein
Scientific

Erasmus Medical Center
P.O. Box 2040
Rotterdam
3015 GD
Netherlands

Phone +31 (0)10 4087414
Email m.hagelstein@erasmusmc.nl

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study acronymRATS-2
Study objectives1. Cognitive linguistic therapy (CLT) is more effective than no-CLT
2. CLT applied zero to three months post onset is more effective than applied three to six months post-onset
Ethics approval(s)Ethics approval received from the local medical ethics committee
Health condition(s) or problem(s) studiedAphasia
InterventionAssessment:
1. Amsterdam-Nijmegen Everyday Language Test (ANELT), scale A
2. ScreeLing: semantic, phonological and syntactic deficits
3. Semantic Association Test (SAT), verbal version
4. Semantic Association words with low imageability (Psycholinguistic Assessment of Language Processing in Aphasia [PALPA])
5. Semantic word fluency (animals, professions)
6. Nonwords Repetition (PALPA)
7. Auditory Lexical Decision (PALPA)
8. Letter fluency (D, A, T)
9. Boston Naming Test
10. Token Test (short version)
11. Spontaneous Speech
12. Partner Communication Questionnaire
13. Aachen Aphasia Test
14. EuroQol quality of life instrument
15. Modified Rankin Scale
16. Barthel Index

Therapy:
Group one: Cognitive Linguistic Therapy (CLT) using BOX or FIKS or a combination of the two, depending on how the language disorder manifests itself in each patient.
BOX is a lexical semantic treatment program, focused on the interpretation of the semantic features of written words, sentences, and texts.
FIKS is a phonological treatment program focused on sound structure and word form, consisting of exercises for selecting and sequencing speech sounds on word-, sentence- and text level. Both the paper versions (for individual therapy) and the computerised versions (for additional therapy with homework) can be used.

Group two: no-CLT: all therapy tasks other than cognitive linguistic exercises are allowed. Treatment focused on the linguistic levels (phonology, semantics and syntax) is not permitted. In practice, this means that the control therapy will contain exercises aimed at improving communicative strategies.
Intervention typeOther
Primary outcome measureThe score at six months post onset on the Amsterdam Nijmegen Everyday Language Test (ANELT), scale A (understandability).
Secondary outcome measures1. Proportion of patients in each treatment group who improve at least seven points on the ANELT with a categorisation of the ANELT into severe (score: ten to 29) and moderate to mild (score: 30-48) communication deficits (ScreeLing)
2. Semantic Association Test (SAT), verbal version
3. Semantic Association words with low imageability, Nonwords Repetition and Auditory Lexical Decision (PALPA)
4. Semantic word fluency
5. Letter fluency
Overall study start date04/09/2006
Completion date04/12/2008

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit85 Years
SexBoth
Target number of participants160
Key inclusion criteria1. Aphasia due to stroke
2. Within three weeks post onset
3. Age 18 to 85 years
4. Language near native Dutch
5. Life expectancy more than six months
Key exclusion criteria1. Severe dysarthria
2. Premorbid dementia
3. Illiteracy
4. Severe developmental dyslexia
5. Severe visual perceptual disorders
6. Existing aphasia
7. Subarachnoidal haemorrhage
8. Recent psychiatric disorder
Date of first enrolment04/09/2006
Date of final enrolment04/12/2008

Locations

Countries of recruitment

  • Belgium
  • Netherlands

Study participating centre

Erasmus Medical Center
Rotterdam
3015 GD
Netherlands

Sponsor information

Erasmus Medical Center (The Netherlands)
Hospital/treatment centre

P.O. Box 2040
Rotterdam
3000 CA
Netherlands

ROR logo "ROR" https://ror.org/018906e22

Funders

Funder type

Research organisation

The Nuts-Ohra Foundation (Stichting Nuts Ohra [SNO]) (The Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/04/2011 Yes No